Antineoplastic Agents Associated With Thyroid Dysfunction

from The JNCI Podcast · host Oxford University Press

Dr. Ole-Petter Hamnvik discusses antineoplastic agents such as immunotherapies and targeted therapies that specifically target signaling pathways in cancer cells are associated with thyroid dysfunction.

Episode metadata supplied by the publisher feed · Published Oct 18, 2011

Embed this episode

Attribution link and audio player

Ready to play

Antineoplastic Agents Associated With Thyroid Dysfunction

0:00 9:56

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The JNCI Podcast?

This episode is 9 minutes long.

When was this The JNCI Podcast episode published?

This episode was published on October 18, 2011.

Can I download this The JNCI Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!